To appeal an Ozempic denial, get the written reason, check your deadline, and send records that answer that exact reason — a missing diabetes record, a "try metformin first" rule, or a renewal rule. Filing rules depend on your plan. Without type 2 diabetes, check whether the plan allows coverage for your actual diagnosis.
The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.
Your diagnosis changes what you should send. The table below matches nine common denial reasons to the proof that answers each one. It also shows what to send if your A1c improves but coverage is denied.
A1c is a blood test that shows your average blood sugar over about three months (NIDDK).
RX Index Decision Verdict: Match the appeal to the denial reason. If type 2 diabetes isn't in your records, check the coverage rule before making the same request again.
- Best for appealing: adults whose records answer a missing-record, step-therapy, preferred-drug, dose-limit or renewal denial.
- Not ideal for repeating the same request: Ozempic for weight loss when the plan excludes that use and no exception applies.
- The factor that matters most: the diagnosis on the request — and the exact words on your denial notice.
No letter can promise approval or add a benefit your plan leaves out. What you can do is make sure the plan used the right rule and saw the right records. That gives the reviewer a specific reason to reconsider.
Find my denial reason · Check my deadline · Use the letter
Find the reason for your Ozempic denial
The reason on your notice decides what you do next. A missing record, an unmet plan rule and a benefit your plan excludes each need a different response. Find the wording closest to yours below.
First, two quick terms. Prior authorization (PA) is a permission slip from your insurer — the plan's review before it agrees to pay for a prescription. A PBM (pharmacy benefit manager) is the company that runs your plan's drug benefit, like CVS Caremark, Express Scripts or OptumRx.
| What you were told | What it can mean | First move | What to send | What decides the next step? |
|---|---|---|---|---|
| "Prior authorization required" at the pharmacy, but no letter | A request may be missing or pending, or you may not have received the decision | Ask your prescriber's office and plan to check the request | Pharmacy message and case number, if available | Whether a coverage decision exists |
| "Missing information" or "incomplete request" | A record didn't make it to the plan | Send exactly what's named; ask if a corrected request is accepted | The specific missing record | Whether the missing record can be supplied |
| "Diagnosis not supported" — but type 2 diabetes is in your chart | The plan didn't see proof of your diagnosis | Send the diagnosis record, or appeal if the office already sent it | Dated diagnosis records and the lab results the policy asks for | What diagnosis evidence the policy requires |
| "Criteria not met" because your A1c is now low, or a renewal was treated like a new start | The plan may be using new-patient rules on a returning patient | Ask which rule was applied: new-start or continuation | Your diagnosis history and current results, plus prior approval dates | Which new-start or continuation rule applies |
| "Step therapy" / "try metformin or another drug first" | The plan requires another drug to be tried first | Show a dated trial, or the documented reason you can't take it | Drug names, dates, results, side effects or reasons it's unsafe — from your record | Whether the required trial or exception is documented |
| "Non-formulary" / "preferred drug available" | Ozempic isn't on your plan's drug list, or the plan prefers another one | Ask for a formulary exception | Prescriber's statement on why the covered options don't fit you | Whether the exception standard is met |
| "Quantity" or "dose limit" | The dose or amount is over a plan limit | Confirm the prescription is right; ask for an exception if needed | Prescriber's reason for that dose or amount | Whether there is an error or a supported exception |
| "Off-label use" / "not covered for weight loss" — and no type 2 diabetes | The request is outside what Ozempic is approved for | Ask your prescriber whether a different medicine fits your real diagnosis | Your real diagnosis only — never an invented one | Whether the plan allows the requested off-label use |
| "Excluded benefit" | Your plan contract leaves this drug or use out | Get the exact plan wording; check whether it was applied correctly | The plan provision, and why it may not apply | Whether the exclusion applies to this request |
Sources: U.S. Department of Labor, HealthCare.gov, CMS exceptions, UHC policy 2026 P 1332-8, Aetna policy 2439-C. This table helps you choose a process. It does not predict whether your plan will approve the request.
The interactive version below does the same matching for you and shows the filing rule. It can also calculate a first-appeal reference date when you know the plan, stage and required date.
Ozempic denial decoder
Match the wording on your notice to the next step and the filing rule. The date fields are optional; the tool will not estimate a deadline when the required plan type, stage or date is not known.
Was it a pharmacy rejection or a written denial?
A "not covered" message at the pharmacy counter isn't the same as a written decision from your plan. It can mean the request was never sent, is still pending, or had a billing error. Before you write anything, find out which one you have.
Ask your plan this, word for word: "Has my plan issued a coverage decision on my Ozempic, or is the pharmacy claim waiting for prior authorization or a billing fix?"
If the plan denied coverage, ask for the written reason and appeal instructions. If no request was sent, ask the office to submit it. If a request is overdue, ask the plan or a free helper how to escalate it; a missing written notice doesn't necessarily mean you have no review rights. A high price at the register can also be your normal cost share, not a denial. Ask the pharmacist which it is. For decoding the pharmacy's message, see GLP-1 pharmacy rejection codes explained.
Check which Ozempic you were denied
Ozempic now comes as a weekly shot and a daily tablet, and their approved uses aren't identical. Make sure the prescription, the request, the denial and the plan's policy all name the same form.
The tablets are new. Novo Nordisk announced U.S. availability of Ozempic 1.5, 4 and 9 mg tablets starting May 4, 2026. Oral semaglutide had been sold as Rybelsus in a different formulation and set of doses (Novo Nordisk).
| Form | What the FDA label approves it for |
|---|---|
| Ozempic injection (weekly pen) | Blood sugar control, along with diet and exercise, in adults with type 2 diabetes. Lowering the risk of heart attack, stroke and death from cardiovascular disease in adults with type 2 diabetes and established cardiovascular disease. Lowering the risk of sustained loss of kidney function, end-stage kidney disease and death from cardiovascular disease in adults with type 2 diabetes and chronic kidney disease. (FDA label) |
| Ozempic tablets (daily, 1.5, 4 or 9 mg) | Blood sugar control, along with diet and exercise, in adults with type 2 diabetes. Lowering the risk of heart attack, stroke and death from cardiovascular disease in adults with type 2 diabetes at high risk for them. No kidney-outcome approval. (FDA label) |
Every use in both labels requires type 2 diabetes. Neither label approves Ozempic for weight management. Cardiovascular means the heart and blood vessels.
A real example of why the form matters: Aetna's 2026 policy lists separate rules and limits for Ozempic tablets and for the injection, including a heart-disease path that applies only to the injection (Aetna 2439-C). If your plan reviewed the wrong form, that's an error worth pointing out.
How long do you have to appeal?
Your time to file and your plan's time to answer are two separate clocks. Both depend on your type of coverage and the appeal stage. Find your plan type first, then use the row that matches.
| Your coverage | First step after a denial | Time to file | Response time after the appeal is received |
|---|---|---|---|
| Job-based plan from a private employer (covered by ERISA, the federal law for most private workplace plans) | Internal appeal | At least 180 days after you receive the denial | Generally up to 30 days before care; 60 days after care; 72 hours for urgent care |
| Marketplace or individual plan (Affordable Care Act rules) | Internal appeal | 180 days after you receive the denial | 30 days before care; 60 days after care; faster if urgent |
| Medicare Part D (Medicare drug coverage) or a Medicare Advantage drug plan | Redetermination — the first Medicare drug appeal | 65 calendar days from the date on the notice | 7 calendar days for benefits; 14 for payment; 72 hours for expedited benefits |
| Medicaid through a health plan (Medicaid managed care) | Plan appeal | 60 calendar days from the date on the notice | State-set period no longer than 30 calendar days; 72 hours if expedited (permitted extensions apply) |
| Federal employee plan (FEHB) | Ask the plan to reconsider | 6 months from the date on the notice | Within 30 days, decide or request needed information. If information is requested, decide within 30 days after receiving it. |
| Medicaid card from the state, TRICARE, VA | Follow your notice | Listed on your notice | Varies |
Sources: DOL, HealthCare.gov, CMS redetermination, 42 CFR 438.402, 42 CFR 438.408, 5 CFR 890.105. This is a federal reference, not your personal deadline. Checked October 21, 2026.
If the denial is from a Medicare Part D drug plan connected with your employer or federal-employee benefits, use that drug plan's Medicare appeal instructions. For example, FEP's Medicare prescription drug plan uses the Medicare appeal process.
A few things trip people up:
- Read the notice and check the rule. If the deadline differs from the applicable rule, call your plan or a free helper (below) right away instead of guessing.
- Some job-based plans have two appeal levels. Each pre-service level generally must be completed within 15 days after that appeal is received, not 30 (DOL). Not every plan has a second level.
- A Medicare "exception" is a different clock. For a request for drug benefits, if your doctor asks your Medicare plan to waive a rule like step therapy, the plan must decide within 72 hours, or 24 hours if expedited, after it gets your prescriber's supporting statement. Payment requests involving an exception use 14 calendar days after the request is received (CMS). That's a request, not the 65-day appeal.
- Don't assume a resubmission pauses your deadline. If the office is "resubmitting," keep your appeal date on the calendar anyway, and ask the plan in writing how the resubmission affects it.
- Missed it already? Call today and ask whether a late or good-cause filing is possible. Don't assume it is — or that it isn't.
- Internal appeals on ERISA-covered job-based plans are free. These plans can't charge you to file a claim or an appeal (DOL).
If you don't know your plan type
The insurer's name on your card doesn't tell you which rules apply. The same company can run job-based, Medicare and Medicaid plans, each with different deadlines.
Call the number on your card and ask: "What type of plan is this, who handles my prescription appeal, what is my filing deadline, and where are those instructions in writing?" If it's through work, add: "Is this plan self-funded, and who is the plan administrator?"
If you can't get a clear answer, your state's Consumer Assistance Program or Department of Insurance can help, for free.
Medicare members: read this before December 7
Medicare drug plans can cover Ozempic for type 2 diabetes, subject to each plan's rules. If your plan said no, you can ask for a redetermination within 65 days of the notice date.
Two more things matter right now:
- Medicare open enrollment runs October 15 to December 7. You can compare how 2027 drug plans handle Ozempic and switch plans for January 1 — while you appeal this year's denial. Check the full plan before switching; the plan must receive your enrollment request by December 7 (Medicare.gov).
- Medicare's $50 GLP-1 program doesn't include Ozempic. The Medicare GLP-1 Bridge covers Wegovy (shot or tablet), Foundayo and Zepbound KwikPen for eligible people, for a $50 copay per month's supply. People with type 2 diabetes aren't eligible for it; their regular Part D plan may cover a GLP-1 instead (Medicare.gov).
Regular Part D does not cover drugs prescribed only for weight loss (federal law, referring to the excluded uses). The Bridge is a separate program outside Part D coverage; its $50 copay does not count toward the Part D out-of-pocket limit, and its current term ends December 31, 2027 (CMS). More detail: Does Medicare cover Ozempic?
How to appeal an Ozempic denial in 7 steps
An appeal asks your plan to take a second look at a decision it already made. A strong one names that decision, shows the plan's own rule, and points to records that answer it. Here's the order that works.
1. Save the notice and write down the dates
Keep the whole notice, including the pages with filing instructions. Write down the date printed on it, the date you got it, the deadline, and the case number. You own this step.
2. Ask for the exact rule and the file the plan reviewed
Ask for the policy or plan rule used to deny you, and the records the reviewer actually saw. That shows you whether the problem is missing proof or a disagreement about the rule.
Use this: "Please send the complete criteria or plan provision applied to this denial, its version or effective date, and the records considered."
On an ERISA-covered job-based plan, you have a right to relevant claim documents free of charge (DOL).
3. Decide: fix, exception, or appeal
A correction fills a gap in the original request. An exception asks the plan to set aside a normal rule, like step therapy or the drug list — your plan's formulary. An appeal challenges a decision already made. Ask which one fits, and keep your appeal deadline on the calendar while the others play out.
A phone call or a doctor-to-doctor talk (a "peer-to-peer") can help. Do not assume it replaces a timely appeal.
4. Match each reason to a record
List every reason the plan gave. Next to each, write the record that answers it. If no record supports a statement, leave it out and ask your prescriber what's appropriate.
One firm rule. Don't claim a side effect you didn't have. If a real side effect is missing from your chart, ask your prescriber to document it accurately. If you never tried metformin, ask whether the plan requires it and whether there's a medical reason it is unsuitable for you.
Your evidence worksheet (copy or print it; fill it in on your own copy):
| Rule or issue in the notice | What the plan received | What's missing or disputed | Record to attach (name, date, page) |
|---|---|---|---|
| Exact Ozempic form, strength and amount | |||
| Diagnosis proof the policy asks for | |||
| New-start or continuation rules | |||
| Past and current lab results, if required | |||
| Required other drug, or the exception reason | |||
| Any benefit exclusion cited | |||
| Anything else the notice names |
"Not known" is a fine answer. It just means you ask the plan or the office for it — it never counts as a rule met.
Your tracking strip:
| Notice date | Date received | Plan type | New start or renewal? | Deadline (and where it came from) | How to submit | Who's filing | Date filed | Confirmation # | Decision due | Next follow-up |
|---|---|---|---|---|---|---|---|---|---|---|
A worked example. Hypothetical: Say you're 54, on a job-based Blue Cross plan, and you've had type 2 diabetes since 2021. Your initial denial is dated October 6, 2026, you received it that day, and the plan confirms ERISA appeal rules apply. It says "diagnosis not supported." The office sent only the prescription and your latest A1c, which is lower now because the medicine is working.
| Exact reason | What went in | What to get | Next move |
|---|---|---|---|
| Diagnosis not supported | Prescription and a recent A1c | The dated record from when you were diagnosed, plus whatever proof this plan's policy accepts | Ask the office whether to send a corrected request or attach the records to an appeal. The 180-day reference from receipt on October 6 is April 4, 2027. Check the filing instructions and confirmed deadline before submitting. |
That's where the example ends — with a clear next step, not a made-up approval.
5. Ask your prescriber for the medical explanation
Your letter explains what decision you're challenging. Your prescriber's statement explains the medical reasons, based on your actual records. Use your prescriber's statement to support the clinical facts in your letter.
Send this to the office (copy, fill in, send):
My Ozempic request was denied under case [number]. The stated reason is "[exact wording from the notice]." Please confirm what was submitted, whether a correction or an appeal is the right next step, and who will file it by [confirmed deadline]. Could you provide the records and a statement that address the rule cited, including the correct Ozempic form and whether this is a new or continuing request? Let me know if you need an authorization form from me.
6. Submit it the way the notice says
Use the appeal instructions on your notice, including any required form and any form naming someone to act for you. Keep a full copy and proof the plan got it — a fax confirmation, portal receipt or tracking number. Follow your program's accepted method; not every plan requires mail.
7. Confirm receipt and set your next follow-up
Confirm receipt promptly and ask for the appeal reference number and the date a decision is due. For an urgent appeal, confirm receipt immediately. If the plan asks for more information, ask exactly what and by when. Write it all on your tracking strip.
Copy this Ozempic appeal letter
Use this as your cover letter when an appeal or redetermination is the right next step. Add any form your plan requires and your supporting records. It doesn't replace your prescriber's medical statement.
Subject: Request for [appeal / redetermination — use the word on your notice] of Ozempic coverage denial — [reference number] To [department named in the notice]: I am requesting review of the decision dated [date] denying coverage for [exact Ozempic form, strength and prescribed amount]. My member ID is [ID]. The denial states: "[exact denial reason]." It cites [policy name, number or plan provision, if given]. I disagree with this decision because [a short, factual explanation tied to that reason]. The attached [record name, date and page] shows [the fact that record supports]. [If it applies: My prescriber's attached statement explains the medical reason for this request.] Please review the attached information under the criteria that apply to my plan and to this [initial / continuing] request. Please confirm receipt and give me the reference number for this review. If anything is missing, please tell me promptly. Please send your written decision and, if the denial is upheld, the specific reason, the rule or plan provision applied, and any further review rights and deadlines. Attachments: [list only what you actually included] [Name, contact information, signature and date]
Add an urgent-review request only when it applies
A fast review depends on a medical standard, not a calendar. Ask your prescriber whether waiting the normal time could seriously harm your health. Being close to a refill date doesn't, by itself, meet that bar. On ERISA-covered job-based plans, a doctor who knows your condition can tell the plan a request is urgent, and the plan must treat it that way (DOL).
If your prescriber supports it, add this paragraph:
I request expedited review because my prescriber states that waiting for the standard review could [specific risk your prescriber supports]. The supporting statement is [attached / being sent by my prescriber].
Check the packet before you send it
Make sure every attachment named in the letter is included and readable. Confirm the form, signature, destination and deadline.
- The denial notice
- Any required plan form, completed and signed
- Your cover letter
- The plan's policy, if you got it
- Records that answer each reason
- Your prescriber's statement, where needed
- A form naming your representative, if someone is filing for you
- A list of what's attached
- A copy for you, and proof of delivery
Want more letter help for other GLP-1s? Use our GLP-1 appeal letter template.
Why was Ozempic denied if my A1c improved?
An improved A1c on treatment doesn't mean your type 2 diabetes diagnosis was wrong (diabetes consensus report). A plan can have separate rules for starting and for continuing a drug. Check whether your renewal was reviewed under the correct rule. Ask which rule your plan used, and send your history and your current results together.
When Ozempic is working, A1c often goes down. That's the point.
Two real 2026 policies show why history matters:
| Plan policy | What it says | What it means for you |
|---|---|---|
| UnitedHealthcare commercial, program 2026 P 1332-8, effective July 1, 2026 | Approves with chart notes plus a qualifying lab result — or, for ongoing treatment when diabetes was diagnosed more than 2 years ago, chart notes confirming the diagnosis. Approvals last 12 months. (UHC) | Your current A1c may not be the only proof that counts. For ongoing treatment of diabetes diagnosed more than 2 years ago, chart notes confirming the diagnosis can meet this criterion. |
| Aetna non-Medicare, policy 2439-C, in its 2026 directory | Has separate new-start and continuation rules. Its continuation section lists a stable maintenance dose for at least 3 months, diagnosis-history criteria, and treatment-response or condition-specific criteria, including an A1c reduction. Ask which criteria apply to your exact drug and request. Approvals last 12 months. (Aetna) | A lower A1c can actually help a continuation request under this policy. Make sure it was reviewed as one. |
These are two policies, not a promise for every plan. Ask for yours.
New insurer? A new plan may treat you as a new start even if your old plan approved you for years. Past approval is useful history. It isn't a guarantee.
Never stop or skip your medicine to push your numbers up for insurance, and don't leave out a current result the plan asks for. Send the whole picture: when you were diagnosed, what you've taken, and how you're doing now.
Can you appeal Ozempic without type 2 diabetes?
You may still have the right to appeal. But a letter can't change Ozempic's label or your plan's rules, and every FDA-approved use of Ozempic requires type 2 diabetes. If your goal is weight management and the plan excludes that use of Ozempic, ask about an appropriate alternative instead of sending the same request again.
Prediabetes, insulin resistance, PCOS and obesity are real conditions, and they're not the same as a type 2 diabetes diagnosis on paper. Don't let anyone add a diagnosis you don't have to get a drug covered.
Public appeal decisions show how this plays out:
| Decision | Plan | Year | What was on file | Outcome |
|---|---|---|---|---|
| NY DFS #202105-137893 | Fidelis Care (Medicaid) | 2021 | Type 2 diabetes; more than 3 months of metformin with A1c still high | Overturned — coverage denial reversed |
| NY DFS #202304-161253 | Fidelis Care (Medicaid) | 2023 | Male, published age band 10–19; obesity, prediabetes, fatty liver; no diabetes | Upheld — reviewer noted semaglutide for obesity is available as Wegovy |
We read the full published New York decision texts on October 21, 2026. They describe individual Medicaid cases decided in 2021 and 2023, not today's rules for every plan. The second case's age band includes minors, so it is not a clean adult comparison.
These decisions show why the diagnosis, treatment history and plan rule matter. They do not establish approval odds or a rule that everyone with diabetes wins and everyone without it loses.
What to do instead:
- Check the denial type. A drug-list exclusion may have an exception process. A benefit exclusion is different: ask whether any exception exists and whether the exclusion was applied correctly.
- Ask your prescriber about the medicine approved for your goal. Wegovy is semaglutide — the same ingredient as Ozempic — and it's FDA-approved for long-term weight management in eligible patients, alongside a reduced-calorie diet and increased physical activity (Wegovy label). It has its own plan rules, so coverage isn't automatic. See Ozempic vs. Wegovy and does insurance cover Wegovy for weight loss?
- On Medicare? The $50 GLP-1 Bridge may cover Wegovy if you qualify (Medicare.gov).
If you have eligible job-based, individual or federal-employee coverage and are considering the Wegovy pen, you can check your plan's drug list or use Ro's free insurance checker. Ro asks your plan about Wegovy, Zepbound and Ozempic pens and emails you a report. It isn't an appeal or a prescription, and it does not check Wegovy pills or Zepbound KwikPen. Ro doesn't coordinate Medicare coverage, and people with Medicaid aren't eligible for treatment on Ro (checker details, insurance rules).
Check my Wegovy pen coverage with Ro
The check is free. If you later join Ro, membership is $39 the first month, then $149 a month, or $74 a month on a 12-month plan paid upfront ($888). Medicine is billed separately, and a licensed provider decides whether treatment is right for you. Prices checked October 21, 2026 on Ro's pricing page.
What if the first Ozempic appeal is denied?
A second "no" isn't always the last word. Read the new decision first — it lists your next step and deadline. Eligible commercial denials can go to independent outside review, Medicare drug appeals have the Independent Review Entity, and Medicaid has a state fair hearing.
This table starts after an appeal to your plan. If you already have a decision from an outside reviewer or hearing officer, follow that decision's next-review instructions.
| Your coverage | Next step to check |
|---|---|
| Job-based or Marketplace | Complete any remaining internal level your plan requires, then request an eligible state or federal external review. In qualifying urgent cases, you can request expedited external review while an internal appeal is pending (HealthCare.gov). Under the federal overview, request it within 4 months after receiving the applicable denial or final determination. A standard decision is due no later than 45 days after receipt of the request, or 72 hours if expedited; the insurer must follow the decision. State rules and eligibility matter. The HHS-administered process is free; another qualifying process may charge up to $25. (HealthCare.gov) |
| Medicare Part D | Reconsideration by the Independent Review Entity. File within 65 calendar days of the plan's redetermination notice. Benefits decisions generally come within 7 calendar days after receipt, or 72 hours if expedited; permitted extensions apply. Payment appeals use 14 days. (CMS) |
| Medicaid managed care | State fair hearing after the plan's appeal. Your state sets the deadline, between 90 and 120 calendar days from the date of the plan's appeal-resolution notice. See the shorter deadline to keep benefits during review. (42 CFR 438.408) |
| FEHB, when this claim follows FEHB rules | OPM review. After the carrier affirms its denial, OPM must receive your request within 90 days after the date of that notice. Different deadlines apply if the carrier does not respond; follow the plan brochure and OPM rules promptly. |
Outside review is mostly for disputes about medical judgment. A pure contract exclusion may not qualify. More detail: external review for GLP-1 denials and GLP-1 appeal levels explained.
We did not verify an Ozempic-specific appeal success rate, so we don't give one.
What if your next refill is at risk?
Tell your prescriber now if a denial could interrupt your treatment. Ask for a plan for your care while coverage is reviewed, and whether a fast review is medically justified. Don't ration, skip or change doses on your own.
On Medicaid through a health plan? If the plan is stopping or cutting a drug it already approved, before that approval ends, you may be able to keep getting it during the appeal. You have to ask by the later of 10 calendar days after the notice was sent or the date the change takes effect. You must also file the appeal on time and meet the rule's other conditions.
If benefits continued during your plan appeal and you lose that appeal, request both a state fair hearing and continued benefits within 10 calendar days after the plan sends the appeal decision to keep benefits continuing. This is separate from the longer deadline to request a hearing. If you lose, the plan may be able to make you repay (42 CFR 438.420).
Paying cash while you wait? Here's what that costs. These manufacturer offers require a valid prescription for an FDA-approved use of Ozempic (offer terms).
| Option | Price (checked October 21, 2026) | The fine print |
|---|---|---|
| Ozempic pen, cash, NovoCare Pharmacy | Standard price: $349 per box at 0.25, 0.5 or 1 mg; $499 at 2 mg. Eligible new patients can pay $199 for each of their first two qualifying 0.25/0.5 mg fills. | At a four-week maintenance schedule, 13 fills cover 364 days and cost $4,537 at $349 each, excluding introductory discounts. Starter-pen duration differs. See the offer terms below. (NovoCare price guide) |
| Ozempic tablets, cash, NovoCare | $149 for 30 tablets at 1.5 mg; $199 at 4 mg; $299 at 9 mg | The $149 strength is the starting dose; the label says it is not effective for blood sugar control. Maintenance-strength prices are $199 or $299 per 30 tablets. These are prices, not instructions to choose or change a dose. (NovoCare terms, tablet label) |
| Ozempic $25 commercial copay offer | As little as $25; up to $100 off a month | Requires eligible commercial coverage for the prescription. Medicare, Medicaid and similar government-benefit enrollees are excluded from this copay offer; FEHB, ACA exchange and state-employee plans are not treated as government programs for it. Separate self-pay offers have different rules. (NovoCare savings terms) |
For NovoCare Pharmacy's $199 offer, "new" means no previous Ozempic injection fill through NovoCare or NovoCare Legacy. The prescription must be written and received by December 31, 2026, and shipped by January 31, 2027 (pharmacy terms).
These manufacturer self-pay offers operate outside insurance. NovoCare Pharmacy's terms prohibit submitting these purchases to any insurer for reimbursement. The retail Ozempic self-pay offer also prohibits counting the cost toward a deductible or out-of-pocket requirement (savings terms). Ordinary cash purchases outside these offers may have different rules; ask your plan before paying. More: Ozempic savings card.
Where to get free help
The right helper depends on your coverage. Start with the contact on your notice, then use these:
| Your coverage | Free help |
|---|---|
| Any private insurance, or not sure | Your state's Consumer Assistance Program or Department of Insurance |
| Job-based plan | U.S. Department of Labor benefits advisors: askebsa.dol.gov or 1-866-444-3272 |
| Medicare | Free counseling through your State Health Insurance Assistance Program (SHIP) — find it on Medicare.gov |
| Medicaid | The plan and state hearing contacts on your notice |
| Federal employee Blue Cross (FEP) | FEP disputed-claim instructions |
Thinking about a new provider for ongoing care and paperwork? Changing providers doesn't change your plan's rules, and a new provider may not take over an appeal already in progress. Read what Ro's appeal support covers before paying, and keep your current deadline either way.
What we actually verified
We checked these public sources on October 21, 2026. They show the general process and the examples on this page. They can't tell us what your plan will decide.
- FDA labels for Ozempic injection (revised May 2026) and Ozempic tablets (revised January 2026): approved uses, tablet strengths, pregnancy guidance.
- Appeal rules: the Department of Labor's claims booklet, HealthCare.gov internal appeal and external review pages, CMS pages on Part D redetermination, exceptions and IRE reconsideration, the federal Medicaid appeal and continuation rules, and FEHB reconsideration rules.
- Plan policies: UnitedHealthcare 2026 P 1332-8 and Aetna 2439-C.
- Public decisions: two New York external-appeal decision texts, read in full; their dates, outcomes and age limits are shown above.
- Prices and terms: NovoCare's Ozempic price guide, pharmacy terms and savings-offer terms; Ro's pricing page. Prices are what each company lists; we didn't buy anything.
- Help routes: HealthCare.gov consumer help, EBSA, Medicare/SHIP and FEP.
- Other access details: Novo Nordisk's tablet launch announcement, the Wegovy label, Medicare enrollment and Bridge rules, and Ro's checker and insurance-support scope.
What we didn't do: we didn't file an appeal, see your plan contract, or review your records. No medical reviewer is claimed for this page.
See how we check sources.
Ozempic denial appeal FAQ
Is it worth appealing an Ozempic denial?
It can be worth appealing when your records answer the denial reason or show that the plan applied the wrong rule. Compare the written reason to your records and your plan's rule. A missing record or a rule applied wrong gives you something specific to fix. If the plan truly excludes your use, ask about an exception or a different treatment instead.
How long does an Ozempic appeal take?
It depends on your plan and stage. A Medicare Part D benefits appeal has a seven-calendar-day decision period after receipt; payment appeals use 14 days. A pre-service appeal under the cited ERISA or ACA rules generally uses 30 days. Urgent appeals under the cited ERISA and Part D rules have a 72-hour maximum.
Why was I denied when Ozempic was already working?
It could be a renewal rule, a new insurer, missing history, or new-patient rules applied by mistake. Ask the office to send your original diagnosis records along with your current results, and ask which rule the plan used. Past approval helps, but it isn't a promise.
Can I appeal if I don't have type 2 diabetes?
You may still be able to appeal. Whether there is a valid basis depends on the plan's coverage and exception rules; every FDA-approved use of Ozempic requires type 2 diabetes. Ask your prescriber whether Wegovy, which is approved for weight management, fits you better.
Can I file the appeal myself?
Usually, yes — you or someone you name can file. Follow your plan's instructions and any required form. Your letter organizes the request, but the medical reasons should come from your prescriber and your records.
Does my A1c have to be high again?
Don't try to raise your blood sugar for insurance. Ask which past and current records your plan accepts and whether your request belongs under continuation rules. The Aetna policy above includes an A1c drop as one continuation criterion.
Do I have to fail metformin first?
Ozempic's FDA label doesn't require it, but your plan may. Get the policy your plan actually used. If metformin isn't right for you, your prescriber must document the real reason for an exception.
Does resubmitting the prior authorization stop my appeal deadline?
Don't count on it. Keep your original appeal date on the calendar, and ask the plan in writing how a resubmission affects your rights. Confirm who's filing before the deadline.
Will the Ozempic savings card help while I'm denied?
The $25 commercial copay offer won't apply while that prescription is denied. Separate manufacturer self-pay offers may help eligible patients: NovoCare Pharmacy currently offers eligible new patients $199 for each of their first two qualifying 0.25/0.5 mg fills. Standard pen prices are $349 or $499 per box, depending on dose. See the cash-price table and offer terms above.
Does Medicare's $50 GLP-1 program cover Ozempic?
No. The Medicare GLP-1 Bridge covers Wegovy, Foundayo and Zepbound KwikPen for eligible people. People with type 2 diabetes aren't eligible for it; their regular Part D plan may cover a GLP-1 instead.
Can a new telehealth provider get my denial reversed?
A new provider may offer ongoing care and paperwork help, but it can't change your plan's rules. Before paying, ask whether it will handle your specific request and any appeal already filed.
If you're considering a different provider or a cash-pay treatment path, The RX Index's Find My GLP-1 Path tool asks a few quick questions, then shows GLP-1 paths and providers that fit your goals, budget, insurance and situation. It doesn't check your coverage or choose an appeal process.
Still not sure which GLP-1 path fits you? Take The RX Index's free Find My GLP-1 Path quiz — about 2 minutes, no signup.
Sources
All checked October 21, 2026, unless noted.
- FDA, Ozempic injection prescribing information (revised 05/2026)
- FDA, Rybelsus and Ozempic tablets prescribing information (revised 01/2026)
- U.S. Department of Labor, Filing a Claim for Your Health Benefits
- HealthCare.gov, Internal appeals and External review
- HealthCare.gov, Consumer help if you have insurance
- CMS, Part D redetermination, Exceptions, IRE reconsideration
- Medicare.gov, Weight loss drugs / Medicare GLP-1 Bridge
- eCFR, 42 CFR 438.402, 438.408, 438.420
- eCFR, 5 CFR 890.105 (FEHB)
- UnitedHealthcare, Program 2026 P 1332-8 (effective 07/01/2026)
- Aetna, 2439-C P05-2025 v4
- NIDDK, The A1C Test & Diabetes
- NY DFS external appeals #202105-137893 and #202304-161253
- NovoCare, Ozempic price guide, pharmacy terms, commercial copay and self-pay savings terms, and savings-offer page
- Ro, Weight loss pricing, insurance, and free insurance checker
- Novo Nordisk, Ozempic tablet U.S. launch announcement (May 1, 2026)
- Novo Nordisk, Wegovy prescribing information
- Medicare.gov, Joining a plan / enrollment periods and Talk to someone / SHIP
- CMS, Medicare GLP-1 Bridge and provider requirements
- Social Security Act, section 1860D-2(e) and section 1927(d)(2)
- eCFR, 29 CFR 2560.503-1
- BCBS FEP, Disputed-claim instructions
- Riddle et al., Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes (2021)